Ignite Creation Date:
2024-05-06 @ 8:07 AM
Last Modification Date:
2024-10-26 @ 11:57 AM
Study NCT ID:
NCT02679755
Status:
COMPLETED
Last Update Posted:
2022-07-27
First Post:
2016-01-22
Brief Title:
Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR HER2- Advanced Breast Cancer
Sponsor:
Pfizer
Organization:
Pfizer
Organization Data
Organization:
Pfizer
Class:
INDUSTRY
Study ID:
A5481037
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pfizer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None